SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Novell (NOVL) dirt cheap, good buy? -- Ignore unavailable to you. Want to Upgrade?


To: Paul Fiondella who wrote (25623)2/25/1999 4:13:00 PM
From: Spartex  Respond to of 42771
 
Novell Inc. Rated New 'Buy' at NMSI

Princeton, New Jersey, Feb. 25 (Bloomberg Data) -- Novell Inc. (NOVL
US) was rated ''buy'' in new coverage by analyst Paul J. Dravis at
NationsBanc Montgomery Securities. The 12-month target price is $26.00 per share.



To: Paul Fiondella who wrote (25623)2/25/1999 9:29:00 PM
From: Phil Jacobson  Read Replies (1) | Respond to of 42771
 
Paul, all -

I just listened to the conference call and thought the most useful (and encouraging) part was Dr. Schmidt's response in the Q&A section where he gave his thoughts on some of the challenges ahead. He recognizes that the biggest issue today is that Novell Sales and Marketing still hasn't learned how to properly articulate the benefits of what they actually offer. He admitted that their core constituency of geeks [his word] understands the power of directories and what Novell is doing in the market, but that Novell hasn't learned how to describe these benefits to "normal people". I find it encouraging that he understands this as I also believe it's their biggest challenge. A problem understood is a problem that can be solved. Eric restated the need to continue focusing his sales and marketing people on learning how to get these benefits articulated to the market, and mentioned that he believes Novell's partners will also be able to help in this regard as they sell Novell products into their own client bases.

Phil